-
Chip giant SK hynix posts record quarterly profit on AI boom
-
Tesla reports higher profits, confirms hefty spending ahead
-
'Big loss' for F1 if Verstappen quits, say McLaren rivals
-
Israeli strikes kill 5 in Lebanon, Beirut to seek truce extension
-
Barca edge Celta but lose match-winner Yamal to injury
-
UK, France agree three-year deal to stop migrant crossings
-
Trump looks for way out on war, but Iran may not oblige
-
Tears and smiles at tribute concert for Swiss fire victims
-
Tesla reports higher profits, topping estimates
-
Manchester City go top of Premier League as Burnley relegated
-
Kane and Diaz send Bayern past Leverkusen into German Cup final
-
Concert pays tribute to Swiss fire disaster victims
-
US stocks rise, shrugging off uncertain ceasefire prospects while oil prices jump
-
Pope hits out at jails in closed-off Equatorial Guinea
-
Atletico beaten again in Elche thriller
-
England rugby great Moody offered 'hope' in battle with motor neurone disease
-
PSG roll over Nantes to move closer to Ligue 1 title
-
Ecuador doctors protest crisis as patients bring own meds to surgery
-
Top Peru ministers quit in protest over stalled US fighter jet deal
-
De La Hoya and Ali's grandson slam proposed federal boxing reform
-
Archer, Burger turn up the heat as Rajasthan beat Lucknow in IPL
-
Trump alleges Democratic-backed Virginia referendum was 'rigged'
-
Archer, Burger help Rajasthan beat Lucknow in IPL
-
Migrants deported from US stranded, 'scared' in DR Congo
-
Raiders expected to make Mendoza first pick in NFL Draft
-
Chelsea sack Rosenior after worst run since 1912
-
Veteran Fijian Botia extends La Rochelle contract to 2027
-
Colombia's ambitious energy transition gets reality check
-
Liam Rosenior sacked as Chelsea manager
-
'Seriously fractured'? Scepticism over Trump's Iran leadership split claim
-
US doesn't dictate terms of trade talks: Carney
-
Mideast war weighs on parent of Durex condoms
-
Greek parliament lifts immunity of MPs probed in EU farm scandal
-
Just a little late: Frankfurt celebrates new airport terminal
-
Germany forward Gnabry confirms he will miss World Cup
-
Liam Rosenior sacked as Chelsea manager: club
-
Shifting goals blur picture of US blockade on Iran
-
US Treasury chief defends pivot to extend Russia oil sanctions relief
-
French teenager Seixas becomes youngest Fleche Wallonne winner
-
New drugs raise hopes of pancreatic cancer breakthrough
-
South Africa coal delay could cause 32,000 deaths, report says
-
French teenager Seixas becomes youngest winner of La Fleche Wallonne
-
Hezbollah supporters defiant after sons killed fighting Israel
-
EU unblocks 90-bn-euro Ukraine loan after Hungary row
-
Russia says will halt flow of Kazakh oil to Germany
-
Merz says climate policy must not 'endanger' German industry
-
Ziggy Stardust lives on at David Bowie London immersive
-
Thousands of London commuters walk to work in underground strike
-
Boeing reports narrowing loss, points to progress on turnaround
-
Oil up, stocks mixed on uncertain prospects for US-Iran ceasefire
Costa Rican sloth antibiotics offer hope for human medicine
The fur of Costa Rican sloths appears to harbor antibiotic-producing bacteria that scientists hope may hold a solution to the growing problem of "superbugs" resistant to humanity's dwindling arsenal of drugs.
Sloth fur, research has found, hosts bustling communities of insects, algae, fungi and bacteria, among other microbes, some of which could pose disease risk.
Yet, experts say, the famously slow-moving mammals appear to be surprisingly infection-proof.
"If you look at the sloth's fur, you see movement: you see moths, you see different types of insects... a very extensive habitat," Max Chavarria, a researcher at the University of Costa Rica, told AFP.
"Obviously when there is co-existence of many types of organisms, there must also be systems that control them," he said.
Chavarria and a team took fur samples from Costa Rican two- and three-toed sloths to examine what that control system could be.
They found the possible existence of antibiotic-producing bacteria that "makes it possible to control the proliferation of potentially pathogenic bacteria... or inhibit other competitors" such as fungi, according to a study published in the journal Environmental Microbiology.
- 'No infection' -
The sloth is a national symbol in laid back Costa Rica, and a major tourist attraction for the Central American country.
Both the two-toed (Choloepus Hoffmanni) and three-toed (Bradypus variegatus) sloth species have seen their populations decline, according to the International Union for the Conservation of Nature's Red List of Threatened Species.
They live in the canopies of trees in the jungle on the Caribbean coast, where the climate is hot and humid.
American Judy Avey runs a sanctuary in the balmy jungle to care for sloths injured after coming into contact with humans or other animals.
She treats and rehabilitates the creatures with a view to releasing them back into the wild.
"We've never received a sloth that has been sick, that has a disease or has an illness," she told AFP.
"We've received sloths that had been burned by power lines and their entire arm is just destroyed... and there's no infection.
"I think maybe in the 30 years (we've been open), we've seen five animals that have come in with an infected injury. So that tells us there's something going on in their... bodily ecosystem."
Avey, who established the sanctuary with her late Costa Rican husband, Luis Arroyo, had never even heard of a sloth back home in Alaska.
Since receiving her first sloth, whom she named "Buttercup," in 1992, she has cared for around 1,000 animals.
- Penicillin inspiration -
Researcher Chavarria took fur samples taken from sloths at the sanctuary to examine in his laboratory.
He began his research in 2020, and has already pinpointed 20 "candidate" microorganisms waiting to be named.
But he said there is a long road ahead in determining whether the sloth compounds could be useful to humans.
"Before thinking about an application in human health, it's important to first understand... what type of molecules are involved," said Chavarria.
An example of this is penicillin, discovered in 1928 by British scientist Alexander Fleming, who discovered that a fungal contamination of a laboratory culture appeared to kill a disease-causing bacteria.
His discovery of the world's first bacteria-killer, or antibiotic, earned him the 1945 Nobel Prize in medicine.
However, microbial resistance to antibiotics has been a growing problem, meaning some medicines no longer work to fight the infections they were designed to treat.
Antimicrobial resistance is a natural phenomenon, but the overuse and misuse of antibiotics in humans, animals and plants has made the problem worse.
The World Health Organization estimates that by 2050, resistance to antibiotics could cause 10 million deaths a year.
"Projects like ours can contribute to finding... new molecules that can, in the medium or long term, be used in this battle against antibiotic resistance," said Chavarria.
M.Qasim--SF-PST